ArticleGlobal spine journal2026
Recommendations of the International Consensus Meeting (ICM) 2025 on Spinal Infections: Part B Tubercular Spondylodiscitis.
Article in Global spine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study DesignSystematic review with guidelines.ObjectiveTo develop evidence-based, globally applicable recommendations for diagnosis and management of Tubercular spondylodiscitis (TBSD) as a part of the International Consensus Meeting (ICM) 2025 on Spinal Infection.MethodsThis article represents a structured, multi-phase international consensus process conducted under the auspices of ICM 2025. Systematic literature reviews were performed using PubMed, Scopus, Web of Science, and ClinicalTrials.gov in accordance with Cochrane methodology. Evidence synthesis was integrated with structured expert deliberation. Consensus statements were developed across 7 domains: screening and initial evaluation, imaging, microbiological diagnosis, anti-tubercular therapy, response monitoring and conservative management, surgical indications, and surgical techniques. Recommendations were finalised through structured voting, with levels of evidence assigned to each statement.ResultsThe consensus emphasises early recognition, routine HIV screening, lesion-specific tissue diagnosis with drug-susceptibility testing, and a multimodal diagnostic strategy. MRI remains the primary imaging modality but lacks specificity for etiological differentiation. Six months of rifampicin-based chemotherapy is sufficient in clinically responding patients, irrespective of surgery. Surgery is indicated for neurological deficit associated with instability or deformity, progressive deterioration, or failure of conservative management. Posterior-only approaches are appropriate in most thoracic and lumbar cases, with anterior surgery reserved for selected indications.ConclusionThe ICM 2025 recommendations provide a comprehensive, evidence-informed framework for the diagnosis and management of TBSD and aim to standardise care while guiding future research priorities worldwide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.